نتایج جستجو برای: metalated flavopiridol

تعداد نتایج: 668  

Journal: :Cancer research 2006
Elliot B Sambol Grazia Ambrosini Rula C Geha Peter T Kennealey Penelope Decarolis Rachael O'connor Yuhsin V Wu Monica Motwani Jin-Hong Chen Gary K Schwartz Samuel Singer

Gastrointestinal stromal tumors (GIST) are characterized by activating mutations in the c-KIT gene which confers ligand-independent activation of the KIT receptor. Imatinib mesylate has been shown to effectively block constitutively active KIT and delay tumor growth. However, resistance to imatinib mesylate is emerging as a major clinical problem and novel therapies are needed. We report that t...

Journal: :Molecular cancer therapeutics 2010
Jen-Ming Huang Michael A Sheard Lingyun Ji Richard Sposto Nino Keshelava

As p53 loss of function (LOF) confers high-level drug resistance in neuroblastoma, p53-independent therapies might have superior activity in recurrent neuroblastoma. We tested the activity of vorinostat, a histone deacetylase inhibitor, and flavopiridol, a pan-Cdk inhibitor, in a panel of multidrug-resistant neuroblastoma cell lines that included lines with wild-type (wt) and transcriptionally ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Glenn Liu David R Gandara Primo N Lara Derek Raghavan James H Doroshow Przemyslaw Twardowski Philip Kantoff William Oh KyungMann Kim George Wilding

PURPOSE Flavopiridol is a cyclin-dependent kinase inhibitor with preclinical activity against prostate cancer cell lines. A Phase II trial was conducted to determine the activity of flavopiridol in patients with metastatic hormone-refractory prostate cancer. EXPERIMENTAL DESIGN A total of 36 patients was enrolled from several institutions and treated with a 72-h continuous infusion of flavopi...

2018
Renier Heijkants Karen Willekens Mark Schoonderwoerd Amina Teunisse Maaike Nieveen Enrico Radaelli Luuk Hawinkels Jean-Christophe Marine Aart Jochemsen

Very little to no improvement in overall survival has been seen in patients with advanced non-resectable cutaneous melanoma or metastatic uveal melanoma in decades, highlighting the need for novel therapeutic options. In this study we investigated as a potential novel therapeutic intervention for both cutaneous and uveal melanoma patients a combination of the broad spectrum HDAC inhibitor quisi...

Journal: :Blood 2007
John C Byrd Thomas S Lin James T Dalton Di Wu Mitch A Phelps Beth Fischer Mollie Moran Kristie A Blum Brad Rovin Michelle Brooker-McEldowney Sarah Broering Larry J Schaaf Amy J Johnson David M Lucas Nyla A Heerema Gerard Lozanski Donn C Young Jose-Ramon Suarez A Dimitrios Colevas Michael R Grever

Despite promising preclinical studies with the cyclin-dependent kinase inhibitor flavopiridol in chronic lymphocytic leukemia (CLL) and other diseases, previous clinical trials with this agent have been disappointing. The discovery of differential protein binding of flavopiridol in human and bovine serum contributed to an effective pharmacokinetic-derived schedule of administration of this agen...

2010
Jen-Ming Huang Michael A. Sheard Lingyun Ji Richard Sposto Nino Keshelava

As p53 loss of function (LOF) confers high-level drug resistance in neuroblastoma, p53-independent therapies might have superior activity in recurrent neuroblastoma. We tested the activity of vorinostat, a histone deacetylase inhibitor, and flavopiridol, a pan-Cdk inhibitor, in a panel of multidrug-resistant neuroblastoma cell lines that included lines with wild-type (wt) and transcriptionally ...

Journal: :Russian Journal of General Chemistry 2012

Journal: :Trends in chemistry 2021

Main-group metalated heterocycles have broad applications in synthesis, drug development, and materials science. In this review, we highlight recent progress synthesizing isolable main-group of boron, indium, silicon, tin, selenium, tellurium via Lewis acid cyclization pathways discuss mechanistic insights. Different from traditional two-step synthetic routes which are constructed first followe...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2003
Richard A Messmann Claudio Dansky Ullmann Tyler Lahusen Audrey Kalehua Jason Wasfy Giovanni Melillo Ivan Ding Donna Headlee William D Figg Edward A Sausville Adrian M Senderowicz

BACKGROUND Flavopiridol is a flavonoid with antiproliferative effects mediated, in part, by inhibition of cyclin-dependent kinases. Clinical manifestations in a previous Phase I trial in patients with refractory malignancies treated with a 72-h flavopiridol infusion included a proinflammatory syndrome consisting of fever, fatigue, and "local" tumor pain with concomitant alterations in plasma ac...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید